Rigel Pharmaceuticals (RIGL) Enterprise Value Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -90.25% |
| Dec 31, 2025 | -100.40% |
| Sep 30, 2025 | -124.41% |
| Jun 30, 2025 | -120.72% |
| Mar 31, 2025 | -55.60% |
| Dec 31, 2024 | -35.81% |
| Sep 30, 2024 | 1.98% |
| Jun 30, 2024 | 23.70% |
| Mar 31, 2024 | 15.53% |
| Dec 31, 2023 | 2.19% |
| Sep 30, 2023 | 23.63% |
| Jun 30, 2023 | 27.82% |
| Mar 31, 2023 | 45.44% |
| Dec 31, 2022 | 53.42% |
| Sep 30, 2022 | 42.97% |
| Jun 30, 2022 | 41.87% |
| Mar 31, 2022 | -173.27% |
| Dec 31, 2021 | -117.99% |
| Sep 30, 2021 | -96.60% |
| Jun 30, 2021 | -65.83% |
| Mar 31, 2021 | 58.98% |
| Dec 31, 2020 | 41.55% |
| Sep 30, 2020 | 32.26% |
| Jun 30, 2020 | 17.69% |
| Mar 31, 2020 | 25.01% |
| Dec 31, 2019 | 23.70% |
| Sep 30, 2019 | 7.05% |
| Jun 30, 2019 | 16.75% |
| Mar 31, 2019 | -35.66% |
| Dec 31, 2018 | -11.05% |
| Sep 30, 2018 | -69.86% |
| Jun 30, 2018 | -64.02% |
| Mar 31, 2018 | 3.91% |
| Dec 31, 2017 | -54.82% |
| Sep 30, 2017 | 20.15% |
| Jun 30, 2017 | 13.31% |
| Mar 31, 2017 | 5.30% |
| Dec 31, 2016 | 40.79% |
| Sep 30, 2016 | 36.54% |
| Jun 30, 2016 | 34.04% |
| Mar 31, 2016 | 35.69% |
| Dec 31, 2015 | 11.79% |
| Sep 30, 2015 | 14.79% |
| Jun 30, 2015 | 18.23% |
| Mar 31, 2015 | 17.52% |
| Dec 31, 2014 | 32.46% |
| Sep 30, 2014 | 31.71% |
| Jun 30, 2014 | 30.05% |
| Mar 31, 2014 | 28.29% |
| Dec 31, 2013 | 28.92% |
| Sep 30, 2013 | -25.55% |
| Jun 30, 2013 | -24.18% |
| Mar 31, 2013 | -22.01% |
| Dec 31, 2012 | -20.43% |
| Sep 30, 2012 | 30.78% |
| Jun 30, 2012 | 27.39% |
| Mar 31, 2012 | -768.67% |
| Dec 31, 2011 | -39.68% |
| Sep 30, 2011 | -1,104.47% |
| Jun 30, 2011 | -765.98% |